sulfadiazine has been researched along with Disease Exacerbation in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
Excerpt | Relevance | Reference |
---|---|---|
"Severe forms of cerebral toxoplasmosis in patients with HIV infection are characterized by a good prognosis in approximately 50% of cases." | 1.38 | Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. ( Ait Hssain, A; Bouadma, L; da Silva, D; Klein, IF; Messika, J; Mourvillier, B; Schmidt, M; Sonneville, R; Wolff, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sonneville, R | 1 |
Schmidt, M | 1 |
Messika, J | 1 |
Ait Hssain, A | 1 |
da Silva, D | 1 |
Klein, IF | 1 |
Bouadma, L | 1 |
Wolff, M | 1 |
Mourvillier, B | 1 |
1 other study available for sulfadiazine and Disease Exacerbation
Article | Year |
---|---|
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Topics: Adult; Antiprotozoal Agents; Comorbidity; Disease Progression; Drug Therapy, Combination; Female; Gl | 2012 |